Sponsor or institution
Clinical trials and research at Centre Paul Strauss
As of November 12, 2026, Find a Trial lists 15 clinical trials run by Centre Paul Strauss that are recruiting, at sites in 5 countries (most in France (15), Argentina (1), Bolivia (1)). By phase: Phase 2 (3). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 15Clinical trials
- 5Countries
Newest trials
All recruiting trials (15)
-
Post-therapy stress symptoms after gynecologic brachytherapy in cervical cancer
This study tests whether patients undergoing uterovaginal brachytherapy for cervical cancer develop post-traumatic stress symptoms and how these symptoms change over up to 5 years.
-
Chemotherapy effects on reflexes that control muscle responses and blood pressure during exercise
This test will see if women finishing chemotherapy for breast cancer have overactive muscle reflexes and altered blood-pressure control that reduce exercise ability compared with similar healthy women.
-
Combination treatment for recurrent head and neck cancer after pembrolizumab failure
This study is testing a new combination treatment for adults with recurrent head and neck cancer who didn't respond to pembrolizumab to see if it can help them feel better and improve their health.
-
Concentric cycling training during chemotherapy for breast cancer patients
This study tests if a special cycling program can help breast cancer patients feel better and stay stronger while they are going through chemotherapy.
-
Investigating the effects of SGLT2 inhibitors on heart issues from breast cancer treatment
This study is testing if a diabetes medication can help protect the hearts of women with localized breast cancer who are receiving certain chemotherapy treatments.
-
Horse-assisted therapy for children undergoing radiotherapy
This study tests whether horse-assisted therapy can help children and teens undergoing radiotherapy for cancer feel better and less anxious during their treatment.
-
Identifying risk factors for gallbladder cancer and gallstone disease
This study is trying to find out what causes gallbladder cancer and gallstone disease by looking at different lifestyle and genetic factors to help with early detection and prevention.
-
Using PET/MRI to improve detection of lymph node metastases in cervical cancer
This study is testing if a new imaging method called PET/MRI can better find lymph node cancer spread in patients with advanced cervical cancer compared to the standard PET/CT scan.
-
Evaluating PET-MRI for assessing treatment response in advanced rectal cancer
This study is testing if PET-MRI scans can help doctors see how well treatment is working for people with advanced rectal cancer before they have surgery.
-
FDOPA PET-guided IMRT simultaneous-integrated boost for recurrent glioblastoma
This trial will try using FDOPA PET scans to guide a higher‑dose simultaneous‑integrated boost IMRT re-irradiation for adults with recurrent glioblastoma to better target tumor while protecting healthy brain.
-
PET-guided higher-dose targeted radiotherapy using a simultaneous integrated boost for partially- or non-operated glioblastoma
This tests whether giving a higher radiation dose to PET-identified aggressive tumor areas with a simultaneous integrated boost helps adults with partially- or non-operated glioblastoma who are not fit for standard Stupp treatment.
-
Using advanced imaging techniques to improve brain cancer diagnosis
This study is testing a new imaging technique to see if adding special scans can help doctors better diagnose brain cancer in patients getting PET/MRI exams.
-
Identifying factors that predict response to PD1 immunotherapy in head and neck cancer
This study is trying to find out what factors can help predict how well PD1 immunotherapy works for patients with advanced head and neck cancer.
-
Evaluation of a supportive care program for elderly patients with digestive cancer
This study is testing whether a new supportive care program can help elderly patients with digestive cancer feel better during their chemotherapy or targeted therapy.
-
Identifying genetic factors affecting treatment response in HER2-positive breast cancer
This study is trying to find out how genetic differences affect how well people with HER2-positive breast cancer respond to treatment and if they experience side effects.
Quick answers
How many clinical trials run by Centre Paul Strauss are recruiting right now?
15, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 5 countries. The most sites are in France (15 trials), Argentina (1 trial), Bolivia (1 trial), Chile (1 trial), Peru (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 3. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.